Bristol’s Nutritionals Business Spins Out; IPO Well-Received By Investors
This article was originally published in The Pink Sheet Daily
Executive Summary
Mead Johnson Nutrition offering breaks health care IPO drought.
You may also be interested in...
RB Eyes MJN, Spiked Supplements, GMP Warning: Health & Wellness Industry News Roundup
RB eyes acquiring MJN; weight loss, ED drugs found in supplements; Unique EnCapsulation has GMP, water, expiration date problems; and SSCI Benchmark panel nominees sought.
Are Emerging Markets Part Of Big Pharma's Core Business?
As Big Pharma companies increasingly look to emerging markets to capture some of the growth lost from the patent cliff in the U.S. and Europe, they are also shifting focus more to branded generics, leaving some investors to question whether companies would be better off spinning out their emerging market units, which would leave behind smaller companies focused on the core business of developing and marketing innovative therapies
Cumberland Pharmaceuticals Raises $85 Million In IPO
First public offering for the pharmaceutical sector in 21 months suggests a financial thaw, but unlikely to spark an additional flood of deals.